Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.

Held M, Pausch C, Huscher D, Pittrow D, Halank M, Beckmann S, Stadler S, Tello K, Grünig E, Opitz C, Delcroix M, Ghofrani HA, Behr J, Skride A, Skowasch D, Vonk-Noordegraaf A, Ulrich S, Klose H, Rosenkranz S, Olsson KM, Hoeper MM, Kopec G

Open source

DOI: 10.1183/23120541.00230-2025
Published: 2025 Nov
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00230-2025,
  title = {Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.},
  author = {Held M and Pausch C and Huscher D and Pittrow D and Halank M and Beckmann S and Stadler S and Tello K and Grünig E and Opitz C and Delcroix M and Ghofrani HA and Behr J and Skride A and Skowasch D and Vonk-Noordegraaf A and Ulrich S and Klose H and Rosenkranz S and Olsson KM and Hoeper MM and Kopec G},
  year = {2025},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00230-2025},
  url = {https://doi.org/10.1183/23120541.00230-2025}
}

RIS

TY  - JOUR
TI  - Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.
AU  - Held M
AU  - Pausch C
AU  - Huscher D
AU  - Pittrow D
AU  - Halank M
AU  - Beckmann S
AU  - Stadler S
AU  - Tello K
AU  - Grünig E
AU  - Opitz C
AU  - Delcroix M
AU  - Ghofrani HA
AU  - Behr J
AU  - Skride A
AU  - Skowasch D
AU  - Vonk-Noordegraaf A
AU  - Ulrich S
AU  - Klose H
AU  - Rosenkranz S
AU  - Olsson KM
AU  - Hoeper MM
AU  - Kopec G
PY  - 2025
JO  - ERJ open research
DO  - 10.1183/23120541.00230-2025
UR  - https://doi.org/10.1183/23120541.00230-2025
ER  -

APA

M, H., C, P., D, H., D, P., M, H., S, B., S, S., K, T., E, G., C, O., M, D., HA, G., J, B., A, S., D, S., A, V., S, U., H, K., S, R., KM, O., MM, H., & G, K. (2025). Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.. ERJ open research. https://doi.org/10.1183/23120541.00230-2025

Source records

pubmed · retrieved 2026-09-26T12:11:52.572Z